These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 8118270)

  • 1. [Expression of the cell surface receptor for thrombin, thrombomodulin, in human ovarian cancer cells].
    Wilhelm S; Wilhelm O; Schmitt M; Möbus V; Kreienberg R; Graeff H
    Gynakol Geburtshilfliche Rundsch; 1993; 33 Suppl 1():202-3. PubMed ID: 8118270
    [No Abstract]   [Full Text] [Related]  

  • 2. Thrombomodulin, a receptor for the serine protease thrombin, is decreased in primary tumors and metastases but increased in ascitic fluids of patients with advanced ovarian cancer FIGO IIIc.
    Wilhelm S; Schmitt M; Parkinson J; Kuhn W; Graeff H; Wilhelm OG
    Int J Oncol; 1998 Oct; 13(4):645-51. PubMed ID: 9735390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel human monoclonal antibody against cervical cancer: its immunoreactivity with normal tube and ovary and with ovarian tumor tissue.
    Nakanishi T; Okamoto T; Nawa A; Suzuki T; Ino K; Wakahara Y; Horibe N; Goto S; Tomoda Y
    Arch Gynecol Obstet; 1995; 256(4):177-84. PubMed ID: 7503589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immuno-histological characterization of OVS1 and OVS2 monoclonal antibodies recognizing human ovarian mucinous cystadenocarcinoma.
    Neungton N; Moongkarndi P; Laohathai K; Neungton S; Juntrachotiwit P
    Asian Pac J Allergy Immunol; 1992 Dec; 10(2):129-34. PubMed ID: 1284830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of various marker substances in human ovarian cancer cell lines of epithelial origin.
    Sekiya S; Tanaka N; Takamizawa H
    Arch Gynecol Obstet; 1990; 248(2):103-10. PubMed ID: 2078056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombomodulin and thrombin localization on the vascular endothelium; their internalization and transcytosis by plasmalemmal vesicles.
    Horvat R; Palade GE
    Eur J Cell Biol; 1993 Aug; 61(2):299-313. PubMed ID: 8223719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New human ovarian cell line OVCCR1/sf in serum-free medium.
    Jozan S; Roché H; Cheutin F; Carton M; Salles B
    In Vitro Cell Dev Biol; 1992; 28A(11-12):687-9. PubMed ID: 1483954
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunocytochemical staining of ovarian tumours with Ov632.
    Owens OJ; Mutch F
    Cytopathology; 1992; 3(3):161-6. PubMed ID: 1511121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a human ovarian carcinoma.
    Rotmensch J; Schwartz JL; Beckett MA; Grdina DJ; Toohill P; Weischelbaum RR
    Anal Quant Cytol Histol; 1989 Oct; 11(5):324-30. PubMed ID: 2478138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of a newly established ovarian carcinoma cell line--OC-3-VGH.
    Chao KC; Ng HT; Chang CC
    Zhonghua Yi Xue Za Zhi (Taipei); 1987 Mar; 39(3):147-52. PubMed ID: 3455323
    [No Abstract]   [Full Text] [Related]  

  • 11. Establishment and characterization of a human ovarian serous cystadenocarcinoma cell line that produces the tumor markers CA-125 and tissue polypeptide antigen.
    Imai S; Kiyozuka Y; Maeda H; Noda T; Hosick HL
    Oncology; 1990; 47(2):177-84. PubMed ID: 2314830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A monoclonal antibody (SZ-53) against thrombomodulin inhibits thrombin-mediated release of t-PA and PGI2 from endothelial cells.
    Zhou Q; Zhao Y; Li P; Bai X; Ruan C
    Nouv Rev Fr Hematol (1978); 1991; 33(4):281-6. PubMed ID: 1664094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Development of a technique for isolation of intact tumor cells from fresh breast or ovarian cancer tissue. Use in analysis of tumor-associated proteolytic factors].
    Harbeck N; Schüren E; Yamamoto N; Schmitt M; Höfler H; Graeff H
    Gynakol Geburtshilfliche Rundsch; 1993; 33 Suppl 1():277-9. PubMed ID: 8118313
    [No Abstract]   [Full Text] [Related]  

  • 14. [Establishment and characterization of a human ovarian adenocarcinoma cell line OC-8611].
    Huang JS
    Zhonghua Zhong Liu Za Zhi; 1989 Nov; 11(6):416-8. PubMed ID: 2634538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel biomarker ARMc8 promotes the malignant progression of ovarian cancer.
    Jiang G; Yang D; Wang L; Zhang X; Xu H; Miao Y; Wang E; Zhang Y
    Hum Pathol; 2015 Oct; 46(10):1471-9. PubMed ID: 26232863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Target therapy of ovarian carcinoma by monoclonal antibodies bearing chemical drugs entrapped in liposomes.
    Qian HN; Li WJ
    Chin Med J (Engl); 1993 May; 106(5):343-7. PubMed ID: 8404276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Development of an experimental model for ovarian cancer invasion using cultured mesothelial cell layer].
    Sawada M; Tanizawa O; Inagaki M; Ozaki M; Shii J; Akedo H
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 Jun; 44(6):725-6. PubMed ID: 1506735
    [No Abstract]   [Full Text] [Related]  

  • 18. Characterization of newly established cell line HUOA from a human ovarian serous cystadenocarcinoma.
    Ishiwata I; Ishiwata C; Kobayashi N; Ishikawa H
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 May; 39(5):831-6. PubMed ID: 3598277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional distribution of thrombomodulin in human brain.
    Wong VL; Hofman FM; Ishii H; Fisher M
    Brain Res; 1991 Aug; 556(1):1-5. PubMed ID: 1657303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human ovarian cancer, cell lines, and primary ascites cells express the human Mullerian inhibiting substance (MIS) type II receptor, bind, and are responsive to MIS.
    Masiakos PT; MacLaughlin DT; Maheswaran S; Teixeira J; Fuller AF; Shah PC; Kehas DJ; Kenneally MK; Dombkowski DM; Ha TU; Preffer FI; Donahoe PK
    Clin Cancer Res; 1999 Nov; 5(11):3488-99. PubMed ID: 10589763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.